Insights Into Hodgkin Lymphoma (HL) 2023

Perspectives of community physicians from across the US on the management of Hodgkin lymphoma (HL) with regard to clinical and nonclinical factors impacting treatment selection

California – February 18, 2023
Purchase Report

Faculty Chair

Joseph Tuscano, MD

University of California Davis Health, Sacramento, CA, USA

More Information

  • Sacramento, CA
  • California

Example Agenda

Download the meeting agenda

View Agenda

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • Assess advisors’ current management of cHL
  • Gain insights into advisors’ perceptions of available therapies and understanding of data
  • Understand the impact of pathways and other nonclinical factors that may affect treatment selection

GEOGRAPHIC REPRESENTATION AND CONTENT DEVELOPMENT

  • Data collection was accomplished through use of audience response system questioning and moderated discussion
  • The group of advisors comprised 10–15 medical oncologists

Purchase Report

Thank you for your interest in Insights Into Hodgkin Lymphoma (HL) 2023.

Complete the form below to receive additional information.